Amedisys Revenue, Profits - AMED Quarterly Income Statement

Add to My Stocks
$120.1 $0.61 (0.51%) AMED stock closing price Sep 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Amedisys stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $411.6M for 2018 Q2 impacts the AMED stock. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Amedisys assets, operating expenses and Amedisys free cash flow. The Amedisys profit and loss statement shows revenue of $411.6M for 2018 Q2. Revenue has grown by 3.09% QoQ for AMED stock.

View and download details of revenue and profits for Amedisys for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Amedisys Revenues or Net Sales
411.6M399.26M404.24M380.16M378.82M370.46M366.3M361.6M360.75M348.82M
Cost Of Goods Sold (COGS)242.56M238.3M238.54M226.64M219.76M215.78M212.6M212.12M206.5M201.83M
Amedisys Gross Profit
169.04M160.95M165.71M153.52M159.05M154.67M153.7M149.47M154.24M146.98M
Research & Development Expense----------
Selling General & Admin Expense123.09M121.35M131.98M125.96M154.27M125.09M135.15M129.89M130.9M131.44M
Income Before Depreciation Depletion Amortization45.95M39.59M33.74M27.55M4.77M29.58M18.58M19.57M23.33M15.53M
Depreciation Depletion Amortization3.13M3.59M4M4.18M4.53M4.41M5.02M5.21M4.97M4.47M
Non Operating Income3.45M2.58M-1.98M3.52M1.02M2.63M4.97M1.03M-
Interest Expense2.14M1.7M1.45M1.33M1.19M1.06M1.62M1.13M1.3M1.11M
Amedisys Pretax Income
44.14M36.88M29.1M24.02M2.56M25.12M14.59M18.19M18.08M10.7M
Provision for Income Taxes10.6M9.56M32.79M9.36M-1.96M9.92M5.62M6.69M7.24M4.38M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations33.54M27.16M-3.85M14.56M4.46M15.13M8.92M11.44M10.7M6.21M
Extraordinary Items & Discontinued Operations----------
Amedisys Profit/ Loss (Net Income)
33.35M27.16M-3.85M14.56M4.46M15.13M8.92M11.44M10.7M6.21M
Average Shares used to compute Diluted EPS34.18M34.59M33.9M34.36M34.33M34.07M33.87M33.82M33.71M33.51M
Average Shares used to compute Basic EPS33.44M33.97M33.9M33.84M33.64M33.44M33.37M33.31M33.2M32.92M
Income Before Nonrecurring Items34.12M27.3M19.39M19.15M21.38M16.02M15.03M12.14M14.11M10.91M
Income from Nonrecurring Items-0.77M-0.14M-23.23M-4.59M-16.92M-0.89M-6.11M-0.7M-3.41M-4.7M
Amedisys Earnings Per Share Basic Net
1.000.80-0.110.430.130.450.270.340.320.19
Amedisys Earnings Per Share Diluted Net
0.980.79-0.110.420.130.440.260.340.320.19
EPS Diluted Before Nonrecurring Items1.000.790.560.560.620.470.440.360.420.33
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Amedisys stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $411.6M for this quarter of 2018 Q2. Our Amedisys revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Amedisys try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The AMED financials along with Amedisys historical stock prices provide a lot of details about the firm.

Amedisys Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
57.74
PS Ratio (price sales ratio)
2.52
Operating Margin
10.4
Net Profit Margin
8.1
Dividend Yield
0%

Other Income Statements - Amedisys Inc Industry Peers

Chemed income statement, Civitas income statement, ENVISION HLTHCR income statement